Oxford to test inhaled version of COVID-19 vaccine with 30 volunteers
MARCH 25, 2021 19:20
Oxford University said on Thursday it was launching a study to investigate immune responses of a nasal administration of its COVID-19 vaccine developed with AstraZeneca, with 30 health volunteers aged 18 to 40 for the initial trial.
British researchers last September said that inhaled versions of COVID-19 vaccine candidates developed by Oxford University and Imperial College will be tested to see if they deliver a localised immune response in the respiratory tract.
The Jerusalem Post Customer Service Center can be contacted with any questions or requests:
Telephone: *2421 * Extension 4 Jerusalem Post or 03-7619056
The center is staffed and provides answers on Sundays through Thursdays between 07:00 AM and 14:00 PM and Fridays only handles distribution requests between 7:00 AM and 12:30 PM
For international customers: The center is staffed and provides answers on Sundays through Thursdays between 7AM and 14PM Israel time Toll
Free number 1-800-448-9291